Mohan Jitendra's Form 4 filing
Astera Labs, Inc. (ALAB) · filed Jul 23, 2025
- Accession no.
- 0001736297-25-000086
- Filed
- Jul 23, 2025
- Trade date
- Jul 21, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions. Open-market sales total $8.60M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mohan JitendraCIK 0001998053 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 21, 2025 | Common Stock | SSaleDisposed | −12,708 | $112.72F2 | −$1,432,445.76 | 4,305,425 | Indirect | |
| Jul 21, 2025 | Common Stock | SSaleDisposed | −12,710 | $112.72F2 | −$1,432,671.2 | 725,413 | Indirect | |
| Jul 21, 2025 | Common Stock | SSaleDisposed | −12,710 | $112.72F2 | −$1,432,671.2 | 725,420 | Indirect | |
| Jul 21, 2025 | Common Stock | SSaleDisposed | −12,710 | $112.72F2 | −$1,432,671.2 | 725,420 | Indirect | |
| Jul 21, 2025 | Common Stock | SSaleDisposed | −12,710 | $112.72F2 | −$1,432,671.2 | 475,421 | Indirect | |
| Jul 21, 2025 | Common Stock | SSaleDisposed | −12,710 | $112.72F2 | −$1,432,671.2 | 475,421 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 16,071 shares sold at prices ranging from $110.7100 to $111.6550, 31,327 shares sold at prices ranging from $111.7800 to $112.7750, 9,561 shares sold at prices ranging from $112.7900 to $113.7500, 13,172 shares sold at prices ranging from $113.9100 to $114.7200, and 6,127 shares sold at prices ranging from $114.9100 to $115.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Referenced by the price of 6 transactions in Table I.